glp-1 drugs glycemic control mechanism Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Mechanism of action of GLP-1

Results Despite heterogeneity in study designs and populations, a largely consistent association was found between GLP-1RA use and a reduced incidence of glaucoma

A newly published clinical investigation in the British Journal of Anaesthesia (May 2025 issue) reveals compelling evidence linking glucagon-like peptide-1 receptor agonists (GLP-1RAs) to impaired gastric emptying (IGE)

New research suggests that switching to a maintenance dose of GLP-1 medication could help lock in weight loss.

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy of the weight-loss medicines it mailed to patients.

PROMOTE HEALTHY FAT LOSS